228 related articles for article (PubMed ID: 24101112)
1. Medical treatment of hepatocellular carcinoma.
Germano D; Tinessa V; Barletta E; Cannella L; Daniele B
Minerva Med; 2013 Oct; 104(5):545-61. PubMed ID: 24101112
[TBL] [Abstract][Full Text] [Related]
2. Medical therapies for hepatocellular carcinoma: a critical view of the evidence.
Villanueva A; Hernandez-Gea V; Llovet JM
Nat Rev Gastroenterol Hepatol; 2013 Jan; 10(1):34-42. PubMed ID: 23147664
[TBL] [Abstract][Full Text] [Related]
3. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
Lencioni R; Chen XP; Dagher L; Venook AP
Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy of hepatocellular carcinoma: current status and future perspectives.
Germano D; Daniele B
World J Gastroenterol; 2014 Mar; 20(12):3087-99. PubMed ID: 24696596
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy for liver cancer: updated review in 2012.
Kudo M
Curr Cancer Drug Targets; 2012 Nov; 12(9):1062-72. PubMed ID: 22920326
[TBL] [Abstract][Full Text] [Related]
7. Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
Kim HY; Park JW
Dig Dis; 2011; 29(3):303-9. PubMed ID: 21829021
[TBL] [Abstract][Full Text] [Related]
8. Molecularly targeted therapy in hepatocellular carcinoma.
Huynh H
Biochem Pharmacol; 2010 Sep; 80(5):550-60. PubMed ID: 20371362
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design.
Llovet JM; Hernandez-Gea V
Clin Cancer Res; 2014 Apr; 20(8):2072-9. PubMed ID: 24589894
[TBL] [Abstract][Full Text] [Related]
11. Advanced HCC: emerging molecular therapies.
Finn RS
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
[TBL] [Abstract][Full Text] [Related]
12. Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Zhu AX
Expert Opin Investig Drugs; 2010 May; 19(5):663-72. PubMed ID: 20367287
[TBL] [Abstract][Full Text] [Related]
13. An update on clinical trials in the treatment of advanced hepatocellular carcinoma.
Lee JK; Abou-Alfa GK
J Clin Gastroenterol; 2013 Jul; 47 Suppl():S16-9. PubMed ID: 23751800
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
Yau T; Pang R; Chan P; Poon RT
Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapy of hepatocellular carcinoma: are we making progress?
Roxburgh P; Evans TR
Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075
[TBL] [Abstract][Full Text] [Related]
16. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
Kudo M
Dig Dis; 2011; 29(3):316-20. PubMed ID: 21829023
[TBL] [Abstract][Full Text] [Related]
17. Improved chemotherapy for hepatocellular carcinoma.
Cao H; Phan H; Yang LX
Anticancer Res; 2012 Apr; 32(4):1379-86. PubMed ID: 22493374
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment of hepatocellular carcinoma: dawn of a new era?
Zhu AX
Ann Surg Oncol; 2010 May; 17(5):1247-56. PubMed ID: 20405329
[TBL] [Abstract][Full Text] [Related]
19. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?
Meza-Junco J; Montano-Loza AJ; Liu DM; Sawyer MB; Bain VG; Ma M; Owen R
Cancer Treat Rev; 2012 Feb; 38(1):54-62. PubMed ID: 21726960
[TBL] [Abstract][Full Text] [Related]
20. Novel molecular therapies in hepatocellular carcinoma.
Faivre S; Bouattour M; Raymond E
Liver Int; 2011 Jan; 31 Suppl 1():151-60. PubMed ID: 21205154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
